Google and Aberdeen work together to fight "death"

Source: bioexploration 2014-9-4 Google has a medical dream, which is always the same This fact is confirmed by the cooperation with Alberta on Wednesday On September 4, Beijing time, calico, a subsidiary of Internet giant Google, and Alberto, a pharmaceutical giant, reached a cooperation in the field of aging disease treatment For the time being, the two sides will invest 250 million US dollars respectively, while for the later cooperation, another 500 million US dollars can be invested It is estimated that the total investment of this cooperation is 1.5 billion US dollars The cooperation between calico and Alberto is conducive to the development of their respective businesses, just as Alberto cooperation can build calico's strength in scientific research, drug research and development, etc And Aberdeen can also use this partnership to get rid of the excessive dependence on the heavyweight drug Humira and expand its business lines According to the cooperation agreement, in the first five years, calico will be responsible for drug discovery and early testing of drugs; in the next 10 years, calico will further enter into the second phase of clinical research of drugs, as well as larger-scale research work Richard Gonzalez, chief executive of Aberdeen, said the partnership with calico would diversify the company's business "It shows that we are committed to exploring new areas of research." Calico, founded in September 2013, is independently operated by Google, focusing on major life-related diseases, mental illness and other aspects Google has invited Arthur Levinson, the current chairman of apple, to be the CEO of the company In addition, Google has also attracted many important people: Hal Barron, the former chief medical officer of Roche, the current research and development director of calico; David Botstein, a professor and famous geneticist of Princeton University, is now calico Cynthia Kenyon, the company's chief scientific officer and biochemist at the University of California, an authority in the field of aging genes, has come to calico full-time as vice president of aging research Despite its young age, calico was founded with a long-term goal of "making people live longer and healthier." Time magazine published an interview on the topic of "Google against death" to describe its vision Cooperation with Alberto is a substantial step towards this goal In 2013, Abercrombie was spun off from Abbott, which owns Humira, a blockbuster drug for rheumatoid arthritis, which contributes $13 billion a year to Abercrombie Abbott is therefore not among the top 10 pharmaceutical companies in 2014 The drug Humira contributes 60% of its revenue to avery every year In order to reduce its over dependence on the drug, avery strengthens drug research and development in arthritis, hepatitis C, cancer, multiple sclerosis and Parkinson's disease, which may be one of the factors contributing to the cooperation to some extent Standing on the wave of the Internet, Google is increasingly using its significant advantages to look down on other industries The health industry is an area that Google has been very optimistic about For example, it is not only concerned about DNA sequencing company 23andMe, but also about DNA data storage company DNA nexus The cooperation with Alberto is also the first time for calico to cooperate with pharmaceutical companies, which also helps the company to strengthen its capabilities in scientific research and pharmaceutical fields.